Barkan, S. E., Melnick, S. L., Preston-Martin, S., Weber, K., Kalish, L. A., Miotti, P., Young, M., Greenblatt, R., Sacks, H., and Feldman, J. (1998). The Women's Interagency HIV study. Epidemiology, 9, 117–125.
Bing, E. G., Kilbourne, A. M., Brooks, R. A., Lazarus, E. F., and Senak, M. (1999). Protease inhibitor use among a community sample of people with HIV disease. Journal of Acquired Immune Deficiency Syndrome, 20, 474–480.
Celentano, D. D., Vlahov, D., Cohn, S., Shadle, V. M., Obasanjo, O., and Moore, R. D. (1998). Self-reported antiretroviral therapy in injection drug users. JAMA, 280, 544–546.
Chesney, M. A., Ickovics, J., Hecht, F. M., Sikipa, G., and Rabkin, J. (1999). Adherence: A necessity for successful HIV combination therapy. AIDS, 13(Suppl. A), S271-S278.
Clumeck, N., and DeWit, S. (2000). Update on highly active antiretroviral therapy: Progress and strategies. Biomedicine and Pharmacotherapy, 54, 7–12.
Deeks, S. G., Smith, M., Holodney, M., and Kahn, J. O. (1997). HIV-1 protease inhibitors: A review for clinicians. JAMA, 277, 145–153.
Detels, R., Munoz, A., McFarlane, G., Kingsley, L. A., Margolick, J. B., Giorgi, J., Schrager, L. K., and Phair, J. P. (1998). Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. JAMA, 280, 1497–1503.
Dunbar-Jacob, J., Burke, L. E., and Puczynski, S. (1995). Clinical assessment and management of adhernce to medical regimens. In P. M. Nicassio and T. W. Smith (Eds.), Managing chronic illness: A biophychosocial perspective. Washington, DC: American Psychologicial Association.
Eron, J. J., Yetzer, E. S., Ruane, P. J., Becker, S., Sawyer, G. A., Fisher, R. L., Tolson, J. M., and Shaefer, M. S. (2000). Efficacy, safety, and adherence with a twice-daily combination lamivudine/zidovudine tablet formulation, plus a protease inhibitor, in HIV infection. AIDS, 14, 671–681.
Flexner, C. (1998). Drug therapy: HIV protease inhibitors. New England Journal of Medicine, 338, 1281–1292.
Friedland, G. H., and Williams, A. (1999). Attaining higher goals in HIV treatment: The central importance of adherence. AIDS, 13(Suppl. 1), S61-S72.
Gallant, J. E. (2000a). Strategies for long-term success in the treatment of HIV infection. JAMA, 283, 1329–1334.
Gallant, J. E. (2000b). Drug Guide 2000: The antiretroviral agents. Posit Aware, 11, 30–31.
Gordillo, V., del Amo, J., Soriano, V., and Gonzalez-Lahoz, J. (1999). Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS, 13, 1763–1769.
Gourevitch, M. N., Wasserman, W., Panero, M. S., and Selwyn, P. A. (1996). Successful adherence to observed prophylaxis and treatment of tuberculosis among drug users in a methadone program. Journal of Addictive Diseases, 15, 93–104.
Hellinger, F. J. (1993). The use of health services by women with HIV infection. Health Services Research, 28, 543–561.
Holzemer, W. L., Corless, I. B., Nokes, K. M., Turner, J. G., Brown, M. A., Powell-Cope, G. M., Inouye, J., Henry, S. B., Nicholas, P. K., and Portillo, C. J. (1999). Predictors of self-reported adherence in persons living with HIV disease. AIDS Patient Care and STDS, 13, 185–197.
Lederman, M. M., and Valdez, H. (2000). Immune restoration with antiretroviral therapies: Implications for clinical management. JAMA, 284, 223–228.
Lin, H. J., Pedneault, L., and Hollinger, F. B. (1998). Intra-assay performance characteristics of five assays for quantification of human immunodeficiency virus type 1 RNA in plasma. Journal of Clinical Microbiology, 36, 835–839.
Lucas, G. M., Chaisson, R. E., and Moore, R. D. (1999). Highly active antiretroviral therapy in a large urban clinic: Risk factors for virologic failure and adverse drug reactions. Annals of Internal Medicine, 131, 81–87.
Moore, J., Schuman, P., Schoenbaum, E., Boland, B., Solomon, L., and Smith, D. (1999). Severe adverse life events and depressive symptoms among women with or at risk for HIV infection in four cities in the United States of America. AIDS, 13, 2459–2468.
Moore, R. D., and Chaisson, R. E. (1999). Natural history of HIV infection in the era of combination antiretroviral therapy. AIDS, 13, 1933–1942.
Moore, R. D., Stanton, D., Gopalan, R., and Chaisson, R. E. (1994). Racial differences in the use of drug therapy for HIV disease in an urban community. New England Journal of Medicine, 330, 763–768.
Musselman, D. L., McDaniel, J. S., Porter, M. R., and Nemeroff, C. B. (1999). Screening for depression. Journal of the Medical Association of Georgia, 88, 47–53.
Myers, J. K., and Weissman, M. M. (1980). Use of a self-report symptom scale to detect depression in a community sample. American Journal of Psychiatry, 137, 1081–1084.
Myers, L. B., and Midence, K. (Eds.). (1998). Adherence to treatment in medical conditions. The Netherlands: Harwood Academic.
Palella, F. J., Jr., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman, D. J., and Holmberg, S. D. (1998). Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection: HIV Outpatient Study Investigators. New England Journal of Medicine, 338, 853–860.
Paterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., Squier, C., Wagener, M. M., and Singh, N. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133, 21–30.
Radloff, L. S. (1977). The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1, 385–401.
Roberts, K. J. (2000). Barriers to and facilitators of HIV-positive patients' adherence to antiretroviral treatment regimens. AIDS Patient Care and STDS, 14, 155–168.
Roca, B., Gomez, C. J., and Arnedo, A. (2000). A randomized, comparative study of lamivudine plus stavudine, with indinavir or nelfinavir, in treatment-experienced HIV-infected patients. AIDS, 14, 157–161.
Samet, J. H., Libman, H., Steger, K. A., Dhawan, R. K., Chen, J., Shevitz, A. H., Dewees-Dunk, R., Levenson, S., Kufe, D., and Craven, D. E. (1992). Compliance with zidovudine therapy in patients infected with human immunodeficiency virus, type 1: Across-sectional study in a municipal hospital clinic. American Journal of Medicine, 92, 495–502.
SAS Institute. (1996). SAS statistical software (Release 6.12). Cary, NC: Author.
Scott, J., Gilvarry, E., and Farrell, M. (1998). Managing anxiety and depression in alcohol and drug dependence. Addictive Behaviors, 23, 919–931.
Shapiro, M. F., Morton, S. C., McCaffrey, D. F., Senterfitt, J. W., Fleishman, J. A., Perlman, J. F., Athey, L. A., Keesey, J. W., Goldman, D. P., Berry, S. H., and Bozzette, S. A. (1999). Variations in the care of HIV infected adults in the United States; results from the HIV Cost and Services Utilization Study. JAMA, 281, 2305–2315.
Simon, G. E., Goldberg, D., Tiemens, B. G., and Ustun, T. B. (1999). Outcomes of recognized and unrecognized depression in an international primary care study. General Hospital Psychiatry, 21, 97–105.
Singh, N., Berman, S. M., Swindells, S., Justis, J. C., Mohr, J. A., Squier, C., and Wagener, M. M. (1999). Adherence of HIV infected patients to antiretroviral therapy. Clinical Infectious Diseases, 29, 824–830.
Singh, N., Squier, C., Sivek, C., Wagener, M., Nguyen, M. H., and Yu, V. L. (1996). Determinants of compliance with antiretroviral therapy in patients with HIV: Prospective assessment with implications for enhancing compliance. AIDS Care, 8, 261–269.
Smith, D. K., Warren, D., Vlahov, D., Schuman, P., Stein, M. D., Greenberg, B. L., and Holmberg, S. D. (1997). Design and baseline participant characteristics of the HIV Epidemiology Research (HER) Study: A prospective cohort study of HIV infection in US women. American Journal of Epidemiology, 146, 459–469.
Sorensen, J. L., Mascovich, A., Wall, T. L., DePhilippis, D., Batki, S. L., and Chesney, M. (1998). Medication adherence strategies for drug abusers with HIV/AIDS. AIDS Care, 10, 297–312.
Stone, V. E., Clarke, J., Lovell, K., and Mayer, K. H. (1997, May). Protease inhibitor-related knowledge, attitudes and patterns of use by gender. Paper presented at the meeting of the National Conference of Women and HIV, Pasadena CA.
Wainberg, M. A., and Friedland, G. (1998). Public health implications of antiretroviral therapy and HIV drug resistance. JAMA, 279, 2000–2002.
Weissman, M. M., Sholomskas, D., Pottenger, M., Prusoff, B. A., and Locke, B. Z. (1977). Assessing depressive symptoms in five psychiatric populations:A validation study. American Journal of Epidemiology, 106, 203–214.